Pseudostat oral vaccine data

DLVRY reported Phase II results in 91 patients. The immunization, involving three days of treatment repeated twice at one-month intervals, led to 10 times fewer acute infective episodes compared to placebo. Rates of infection had been similar in the two groups prior to immunization. ...